We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UCG:MILUniCredit S.p.A. Analysis

Data as of 2026-05-23 - not real-time

€72.11

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

UniCredit is trading at a price that sits comfortably above its 20‑day, 50‑day and 200‑day simple moving averages, signaling a short‑term bullish bias. The RSI around the mid‑50s suggests momentum remains intact without entering overbought territory. A bullish MACD crossover further supports the upside bias, while the stock is hovering just below its identified resistance level. Volume trends are easing, which may temper the pace of any rally but does not negate the technical strength. The equity is priced at a PE ratio well below the industry average, indicating a valuation discount. Additionally, a dividend yield above 4% with a modest payout ratio underscores income appeal.
Fundamentally, revenue growth of roughly 6% and a solid ROE above 16% reflect a resilient earnings base, and the balance sheet shows ample cash offsetting its debt load, reducing leverage concerns. The recent decision to divest a portion of its Russian operations reduces geopolitical exposure and aligns the group with a strategic focus on international payments. Analyst consensus remains bullish with a median target price implying upside of over 15%, while the market sentiment index is in “Extreme Greed” territory, suggesting momentum may persist. Given the combination of undervalued multiples, sustainable dividend, and strategic repositioning, the stock presents a compelling case for both income‑focused and growth‑oriented investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • price above key SMAs
  • bullish MACD signal
  • upcoming earnings catalyst

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation discount to peers
  • sustainable dividend yield
  • strategic Russia divestment reducing geopolitical risk

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • low beta and stable cash generation
  • consistent dividend income
  • focus on international payments growth

Key Metrics & Analysis

Financial Health

Revenue Growth6.40%
Profit Margin44.62%
P/E Ratio9.9
ROE16.98%
ROA1.34%
P/B Ratio1.6
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI58.7
Support€63.05
Resistance€72.79
MA 20€69.14
MA 50€66.54
MA 200€67.34
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Target Price€84.02
Upside/Downside16.52%
GradeUndervalued
TypeBlend
Dividend Yield4.46%

Risk Assessment

Beta0.50
Volatility37.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.